Treatment Decision-making in Patients With Recurrent High-grade Glioma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04013828|
Recruitment Status : Recruiting
First Posted : July 10, 2019
Last Update Posted : July 12, 2019
|Condition or disease|
|Malignant Glioma Life Experiences|
High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experience recurrence of tumour growth. At time of recurrence, the treatment possibilities can include surgery, oncological treatment and/or palliative care.
In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs.
Little is known about how the patients and their close relatives experience the recurrence and the decision-making process.
The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence.
Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis.
The study is part of a larger PhD-study.
|Study Type :||Observational|
|Estimated Enrollment :||25 participants|
|Official Title:||Recurrent High-grade Glioma: Experiences of Patients and Their Close Relatives During the Treatment Decision-making Process.|
|Actual Study Start Date :||May 6, 2019|
|Estimated Primary Completion Date :||July 2020|
|Estimated Study Completion Date :||March 2022|
Patients with recurrent high-grade glioma
Close relatives of patients with recurrent high-grade glioma
- Experiences of patients and relatives [ Time Frame: Interviews are performed 2-6 weeks after the decision-making ]How patients and their close relatives experience the decision-making process
- Involvement preferences [ Time Frame: Interviews are performed 2-6 weeks after the decision-making ]The preferences of patients and relatives for being involved in the decision-making.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04013828
|Contact: Helle von Essen, PhD-student||+45 2388 email@example.com|
|Contact: Karin Piil, Ass. profes.||+45 3545 0733||Karin.Piil@regionh.dk|
|Copenhagen University Hospital; Rigshospitalet||Not yet recruiting|
|Contact: Helle von Essen, PhD-student +45 23881722 firstname.lastname@example.org|
|Odense University Hospital||Recruiting|
|Contact: Helle von Essen, PhD-student +4523881722 email@example.com|
|Study Director:||Frantz Rom Poulsen, Professor||Department of Neurosurgery Odense University Hospital DK-5000 Odense C DENMARK|